Target intelligence / Profile preview

Thiamin pyrophosphokinase 1 (TPK1)

Target
TPK1
Molecular classification
Enzyme
01

Overview

Thiamin pyrophosphokinase 1 (TPK1) is a cytosolic enzyme that catalyzes the phosphorylation of thiamine (vitamin B1) to thiamine pyrophosphate (TPP), a crucial cofactor required for several mitochondrial enzymes involved in energy metabolism—particularly in the glycolysis and Krebs cycle pathways. TPK1 typically exists as a homodimer, with its function being essential for cellular energy homeostasis. Mutations in the TPK1 gene can impair the conversion of thiamine to TPP, leading to metabolic dysfunction and neurological syndromes collectively classified as thiamine metabolism dysfunction syndrome-5 (THMD5). TPK1 is also being evaluated as a biomarker in cancer, where its increased expression may facilitate tumor metabolism and could predict responsiveness to certain therapies[1][2][3][4][5].

Other names
PP20THMD5HTPK1hTPK1placental protein 20thiamine pyrophosphokinase 1thiamine kinasethiamine diphosphokinase
02

Mechanism of action

Drugs (like thiamine supplements) act by increasing substrate availability for TPK1, thereby boosting thiamine pyrophosphate synthesis in cases of deficiency.

03

Biological functions

Conversion of thiamine (vitamin B1) to thiamine pyrophosphate (TPP)Energy metabolismCofactor biosynthesis for mitochondrial enzymes (e.g., those involved in glycolysis and the Krebs cycle)
04

Disease associations

Neurological dysfunction (including ataxia, psychomotor retardation, progressive dystonia, lactic acidosis)Thiamine metabolism dysfunction syndrome-5 (THMD5)Cancer (potential biomarker in tumor thiamine metabolism and possible response to statin therapy)
05

Safety considerations

Genetic defects in TPK1 can lead to severe metabolic and neurological consequences due to impaired thiamine utilizationNo known safety concerns with inhibition, as loss-of-function is pathogenic
06

Interacting drugs

No drugs are specifically approved for direct inhibition or activation. However, thiamine and analogs are relevant as substrates and clinical treatments for deficiency states.

1 more in the full profile.

07

Biomarkers

TPK1 expression level (potential biomarker for thiamine metabolism and in certain cancers, e.g., breast cancer, to predict anti-tumor response to statin therapy)

Beyond the preview

Go deeper on Thiamin pyrophosphokinase 1 (TPK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thiamin pyrophosphokinase 1 (TPK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call